Biophytis SA signed a contract to receive ?10 million in funding on November 19, 2021. The transaction will include participation from existing investor Kreos Capital Management (UK) Limited. The company will issue simple bonds of ?7.8 million and convertible bonds of ?2.2 million. The loan includes four tranches of respectively ?2.5 million, ?3 million, ?2.5 million and ?2 million. Investor will receive share subscription warrants for a total amount of approximately ?1 million. Interest accrues on the principal remaining due at a fixed interest rate of 10.00% per annum for simple bonds and at a rate of fixed interest of 9.5% per annum on convertible bonds. Simple bonds will be repaid in 36 monthly installments, after deferral of repayment of the nominal amount until April 2022. The company will repay the convertible bonds to their principal amount by March 31, 2025 at the latest, unless they are converted beforehand into shares of Kreos Capital's choice, at a fixed conversion price of ?0.648. The loan is senior unsubordinated debt. It was guaranteed by the pledge of certain assets. The company will issue 2,218,293 stock warrants giving the right to subscribe to new ordinary shares, at the rate of one share and are exercisable for a period of 7 years from their date of issue with exercise price of ?0.56. The first two tranches were drawn upon signing the contract on November 19, 2021, the third tranche can be drawn until December 31, 2021, and the last tranche can be drawn until March 31, 2022